Behavioral effects of the putative anxiolytic (±)-1-(2,5-Dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2) in rats and mice

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 2, 1996, Pages 355-361

  Scorza, M C ^a   Reyes Parada, M ^a   Silveira, R ^a   Viola, H ^b   Medina, J H ^b   Viana, M B ^c   Zangrossi Jr , H ^c   Graeff, F G ^c  

^a INSTITUTO DE INVESTIGACIONES BIOLÓGICAS CLEMENTE ESTABLE   (Uruguay)

^b Facultad de Medicina   (Argentina)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

ALEPH 2; Amnesia; Anxiolysis; Elevated plus maze; Elevated T maze; Hole board; Locomotor activity; Mouse; Rat; Sedation

Indexed keywords

MURINAE; ANIMALIA;

2 AMINO 1 (4 ETHYLTHIO 2,5 DIMETHOXYPHENYL)PROPANE; ALEPH 2; ANXIOLYTIC AGENT; PHENETHYLAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY NEUROSIS; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MAZE TEST; MEMORY; MOTOR RETARDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEDATION; TRANQUILIZING ACTIVITY;

2,5-DIMETHOXY-4-METHYLAMPHETAMINE; AMNESIA; AMPHETAMINES; ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; MALE; MEMORY, SHORT-TERM; MICE; MOTOR ACTIVITY; RATS; RATS, WISTAR; SEROTONIN AGONISTS;

EID: 0030011337     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02149-3     Document Type: Article

References (23)

1. Barrett, J. E.; Vanover, K. E. 5-HT receptors as targets for the development of novel anxiolytic drugs: Models, mechanism and future directions. Psychopharmacology (Berlin) 112:1-12; 1993.
2. 3 antagonists and benzodiazepines: Their comparative behavioural pharmacology. Chichester, England: Wiley; 1991:133-157.
3. Cruz, A, P. M.; Frei, F.; Graeff, F. G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:171-176; 1994.
4. 1A receptors in anxiety. In: Briley, M.; File, S. E., eds. New concepts in anxiety. Boca Raton, FL: CRC Press; 1991:94-129.
5. Feighner, J. P.; Merideth, C. H.; Hendrickson, G. A. Double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder. J. Clin. Psychiatry 43:103-107; 1982.
6. File, S. E. What can be learned from the effects of benzodiazepines on exploratory behavior? Neurosci. Biobehav. Rev. 9:45-54; 1985.
7. File, S. E.; Zangrossi, J. R. H.; Viana, M. B.; Graeff, F. G. Trial 2 in the elevated plus-maze: A different form of fear? Psychopharmacology (Berlin) 111:491-494; 1993.
8. Florvall, L.; Fagervall, Y.; Ask, A.-L.; Ross, S. B. Selective monoamine oxidase inhibitors. 4. 4-Aminophenethylamine derivatives with neuron-selective action. J. Med. Chem. 29:2250-2256; 1986.
9. Gammans, R. E.; Stringfellow, J. C.; Hvizdos, A. J.; Seidehamel, R. J.; Cohn, J. B.; Wilcox, C. S.; Fabre, L. F.; Pecknold, J. C.; Smith, W. T.; Rickels, K. Use of buspirone in patients with generalized anxiety disorder and coexisting depressive symptoms. A meta-analysis of eight randomized controlled studies. Neuropsychobiology 25:193-201; 1992.
10. 2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 35:2505-2511; 1984.
11. Graeff, F. G.; Viana, M. B.; Tomaz, C. The elevated T-maze, a new experimental model of anxiety and memory: Effect of diazepam. Braz. J. Med. Biol. Res. 26:67-70; 1993.
12. Handley, S. L.; Mithani, S. Effects of alpha-adrenoceptor agonists in a maze-exploration model of "fear"-motivated behaviour. Naunyn Schmiedebergs Arch. Pharmacol. 327:1-5; 1984.
13. Hjorth, S.; Carlsson, A.; Lindberg, P.; Sanchez, D.; Wikstrom, H.; Arvidsson, L.-E.; Hacksell, U.; Nilsson, J. L. G. 8-Hydroxy-2-(di-N-propylamino)-tetralin, 8-OH-DPAT, a potent selective simplified ergot congener with central 5-HT-receptor stimulating activity. J. Neural Transm. 55:169-188; 1982.
14. 1C receptors. Neurosci. Biobehav. Rev. 16:95-105; 1992.
15. Lister, R. G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin) 92:180-185; 1987.
16. Nichols, D. E. Medicinal chemistry and structure-activity relationships. In: Cho, A. K.; Segal, D. S., eds. Amphetamine and its analogs: Psychopharmacology, toxicology and abuse. San Diego, CA: Academic Press; 1994:3-41.
17. Nichols, D. E.; Marona-Lewicka, D.; Huang, X.; Johnson, M. P. Novel serotonergic agents. Drug Des. Discov. 9:299-312; 1993.
18. Pellow, S.; Chopin, P.; File, S. E.; Briley, M. Validation of open : closed arm entries in the elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14:149-167; 1985.
19. Pellow, S.; File, S. E. Evidence that the β-carboline, ZK 91296, can reduce anxiety in animals at doses below those causing sedation. Brain Res. 363:174-177; 1986
20. Reyes-Parada, M.; Scorza, Ma. C.; Silveira, R.; Dajas, F.; Costa, G.; Tipton, K. F.; Cassels, B. K. Monoamine oxidase inhibitory effects of some 4-aminophenethylamine derivatives. Biochem. Pharmacol. 47:1365-1371; 1994.
21. Shulgin, A.; Shulgin, A. In: PIHKAL: A chemical love story. Berkeley, CA: Transform Press; 1991:464-467.
22. Viana, M. B.; Tomaz, C.; Graeff, F. G. The elevated T-maze: A new animal model of anxiety and memory. Pharmacol. Biochem. Behav. 49:549-554; 1994.
23. Wolfman, C.; Viola, H.; Paladini, A.; Dajas, F.; Medina, J. Possible anxiolytic effects of Chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol. Biochem. Behav. 47:1-4; 1994.